Figure4: Distribution of AP in our study groups. In patients without tumor 63.2 % are of normal activity, 36.8% are pathological elevated. Patients with tumor but without bone metastasis show normal activity in 48.3% and elevated levels of AP in 51.7%. The AP levels were normal in 47.1% of all patients with known bone metastasis and elevated in 52.9%.